Novo Nordisk: Managing Sustainability at Home and Abroad Harvard Case Solution & Analysis

This case study addresses challenges and the opportunities faced by Danish pharmaceutical company Novo Nordisk with regard to its sustainability strategy in China as of 2012. Novo Nordisk is recognized for striving to integrate its business activities in a fiscally, environmentally, and socially responsible manner, and several Novo Nordisk staff proudly refers to the Novo Nordisk as a "triple bottom line (TBL) business."

Novo Nordisk Managing Sustainability at Home and Abroad Case Study Solution

Novo Nordisk has been active in China for greater than 50 years; nevertheless, since the Chinese market has grown enormously, a more sedentary Western lifestyle along with this increase in prosperity have led to growing difficulties with obesity. As a consequence, China's insulin market is booming. Novo Nordisk so faces new challenges concerning how best to arrange its TBL application in a sense that ensures a thorough strategy through the organization, yet permits Novo Nordisk China to adopt initiatives that fit the Chinese business context. Moreover, with ever-increasing competition for access to China's lucrative insulin market, the competitions of Novo Nordisk are also engaging in sustainability, which must use sustainability as a wellspring of competitive advantage, and hints that Novo Nordisk must keep innovating to distinguish itself.

PUBLICATION DATE: September 07, 2012 PRODUCT #: W12186-HCB-ENG

This is just an excerpt. This case is about STRATEGY & EXECUTION

Novo Nordisk: Managing Sustainability at Home and Abroad Case Solution Other Similar Case Solutions like

Novo Nordisk: Managing Sustainability at Home and Abroad

Share This